Biovectra Inc.

Activities: Ingredients

Trending Articles

  1. Scleroderma treatment by Certa Therapeutics granted US FDA fast track FT011 is a novel, first-in-class oral therapy for the treatment of chronic fibrosis in multiple organs
  2. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  3. Indian government bans three medicines owing to health risks Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
  4. Dickson achieves ISO 14001 certification ISO 14001 certification highlights a companies' long-term efforts to manage its environmental impact
  5. The key role of IVDs in healthcare: challenges to commercialisation and access In simple terms, in vitro diagnostic (IVD) tests are done on samples such as blood or tissue that have been taken from the human body. IVDs can detect diseases, conditions and...

Upcoming event

Interphex

16-18 April 2024 | Conference and Exhibition | New York, US See all

Related Content

Manufacturing

BioVectra unveils single-use microbial fermentation technology

Benefits include a decreased risk of contamination, and the elimination of costly and time-consuming cleaning and sterilisation between batches
Manufacturing

Abec to supply fermentation tech for Biovectra plant

The single-use fermentation solutions will enhance the company’s microbial fermentation processes and provide faster turnaround product to product and between batches
Manufacturing

Mallinckrodt sells BioVectra CDMO for $250 million

The Canadian CDMO will continue to supply an API for UK-based Mallinckrodt's specialty brands business under a long-term arrangement
Manufacturing

Questcor Pharmaceuticals to acquire BioVectra

Deal enables Questcor to secure further Acthar manufacturing process trade secrets
Subscribe now